DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Sufentanil and Ropivacaine

Information source: Fudan University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Anesthesia Complications

Intervention: 0.25 sufentanil (Drug); 0.5µg/ml sufentanil (Drug); 0.1% ropivacaine (Drug)

Phase: N/A

Status: Completed

Sponsored by: Fudan University

Official(s) and/or principal investigator(s):
Zeyong Yang, M.D., Principal Investigator, Affiliation: Fudan University, Shanghai Jiaotong University

Summary

The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.

Clinical Details

Official title: Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Primary outcome: VAS(visual analog pain score)

Detailed description: A prospective study of 120 full-term parturients receiving labor analgesia were randomly assigned into 2 groups: the 0. 5Sufen group (N=60), the 0. 25Sufen group (N=60).

Eligibility

Minimum age: 25 Years. Maximum age: 35 Years. Gender(s): Female.

Criteria:

Inclusion Criteria: 1. Patients had regular prenatal examinations at the outpatient clinic; 2. They were between 25 to 35 years of age) 3. They had a gestational age ≥37 weeks and < 42 weeks; 4. They had an estimated fetal weight ≥ 2,500 g and < 4,200 g. Exclusion Criteria:

- a history of spinal surgery,

- platelet count <100×109 /L ,

- coagulation disorder,

- sensorimotor disorder of lower extremity,

- leg pain,

- puncture point infection,

- heart disease history,

- pulmonary disease,

- liver and renal function disorder and

- a history of neuropsychiatry drugs.

Locations and Contacts

Additional Information

Starting date: April 2014
Last updated: June 30, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017